Prelude Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,837
| Closed | -$507K | – | 1480 |
|
|
2021
Q2 | $507K | Buy |
5,837
+1,700
| +41% | +$148K | 0.02% | 737 |
|
|
2021
Q1 | $341K | Hold |
4,137
| – | – | 0.01% | 737 |
|
|
2020
Q4 | $376K | Sell |
4,137
-13,884
| -77% | -$1.26M | 0.01% | 445 |
|
|
2020
Q3 | $720K | Buy |
18,021
+2,573
| +17% | +$103K | 0.03% | 213 |
|
|
2020
Q2 | $530K | Buy |
+15,448
| New | +$530K | 0.03% | 273 |
|